Category:
Preclinical Research Services
CAS NO:
N/A
Standard:
ChP,
Alvespimycin (17-AAG) is a semi-synthetic Hsp90 inhibitor derived from geldanamycin, utilized in oncology research. Its core synthesis involves chemical modification of the benzoquinone moiety to enhance solubility and pharmacokinetic profiles. Formula: C42H56N4O8; CAS No.: 39723-17-6.
Restricted to investigational use only; not approved for clinical therapy. Requires storage at -20°C under inert atmosphere. Personnel must utilize PPE due to potential cytotoxicity and mutagenic risks associated with benzoquinone derivatives.